NIH-funded research Career grant

Understanding how aging affects the blood-brain barrier and protein transport

Official title: Validation and Kinetic Characterization of Blood-Cerebrospinal Fluid Barrier-Traversing Proteins in Aging With Library-Free Multiplexed Targeted Proteomics

Funded at Harvard Medical School · NIH-10948161 · Data updated 2026-11-12

This study is looking at how a part of the brain that helps protect it changes as we get older, with the hope of finding new ways to treat age-related diseases by better understanding how proteins move from our blood to the brain.

More Aging research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 3, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$125,172
NIH project number1K99AG088297-01
Project IDNIH-10948161 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing age-related cognitive decline or neurological conditions.

Less likely to help

Patients with acute neurological injuries or those not experiencing age-related changes may not benefit from this research.

What this research studies

This research investigates the choroid plexus, a key part of the blood-brain barrier, and how its function changes as we age. By using advanced proteomic techniques, the study aims to identify how proteins are transported from the blood to the cerebrospinal fluid, which could lead to new treatments for age-related diseases. The research focuses on developing methods to detect and quantify proteins in challenging biological samples, enhancing our understanding of the aging process. Patients may benefit from insights that could lead to innovative therapies targeting the blood-brain barrier.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for age-related neurological disorders by improving drug delivery across the blood-brain barrier.

How similar studies have gone: Previous research has shown promise in understanding the blood-brain barrier's role in aging, but this specific proteomic approach is relatively novel.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Shuken, Steven Robert — Harvard Medical School
  • Study coordinator: Shuken, Steven Robert

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.